Print
	Email
	Text size
	Comment

OrthoMimetics, a technology spin-out from the Cambridge-MIT Institute, has secured £5 million from a consortium of investors.

The Series A funding round was led by Oxford Capital Partners and included Schroders Investment Management, Sloane Robinson Private Equity and a global investment bank.

OrthoMimetics, which specialises in medical-device technology for the repair and regeneration of bone and soft-tissue damage, will use the funds to advance the development of its first two products.

Oxford Capital Partners’ investment was led by director David Mott, who said: “We believe OrthoMimetics has the potential to make an important contribution to orthopaedic medicine and has already attracted the attention of major medical device companies.”

Comments [0]